Cryoglobulinemic vasculitis as an extrahepatic manifestation of HCV infec- tion
https://doi.org/10.30629/0023-2149-2020-98-9-10-709-712
Abstract
The problem of viral hepatitis C remains highly relevant despite the recent signifi cant advancements in the diagnosis and treatment of this pathology. Chronic hepatitis C is a systemic disease with extrahepatic manifestations. Autoimmune processes leading to cryoglobulinemia can contribute to their development. Basic clinical manifestations include cutaneous vasculitis with palpable purpura, arthralgia-myalgia, neuropathy, and renal complications such as glomerulonephritis. Polyneuropathies develop much earlier than hepatic encephalopathy, which is characteristic of liver damage. A clinical case represented in the article was noted in a patient with a long-term course of viral hepatitis C, manifested with pronounced neurological symptoms and the development of cryoglobulinemic vasculitis. In this case, of all the applied methods of treatment, only adequately conducted antiviral therapy contributed to the stabilization of the clinical manifestations of cryoglobulinemia. The promptness of antiviral therapy is of signifi cant importance, since it is a possibility to prevent the development of severe autoimmune pathology.
About the Authors
A. E. GeraskinRussian Federation
Geraskin Alexander Evgenievich — MD, PhD, Associate Professor of the Department of Hospital Therapy
430005, Saransk
L. M. Mosina
Russian Federation
430005, Saransk
L. V. Chegodaeva
Russian Federation
430005, Saransk
References
1. Global hepatitis report, 2017. World Health Organization. [Electronic resource]. URL: http//apps.who.int/iris/bitstream/10665/255016/1/9789241565455-eng.pdf?ua=1.
2. Strunz B., Hengst J., Wedemeyer H., Björkström N.K. Irreversible impact of chronic hepatitis C virus infection on human natural killer cell diversity. Cell Stress. 2018;2(8):216–218.
3. Damulin I.V., Pavlov Ch.S. Neurological disorders in viral hepatitis C. Russian Medical Journal. 2016;11:707–712. (in Russian)
4. Mariotto S., Ferrari S., Monaco S. HCV-related central and peripheral nervous system demyelinating disorders. Infl ammation & Allergy — Drug Targets. 2014;13(5):299–304.
5. Flores-Chávez A., Carrion J. A., Forns X., Ramos-Casals M. Extrahepatic manifestations associated with Chronic Hepatitis C Virus Infection. Rev. Esp. Sanid. Penit. 2017;19:87–97.
6. Kuna L., Jakab J., Smolic R., Wu G. Y., Smolic M. HCV Extrahepatic Manifestations. J. Clin. Transl. Hepatol. 2019;7(2):172–182.
7. Svechnikov E.V., Sergeev Yu.V., Dudnik V.S. Extrahepatic manifestations of chronic viral hepatitis. Immunology, allergology, infectology. 2007;3:67–71. (in Russian)
8. Karyagina M.S., Plotnikova E.Yu., Baranova E.N., Vorosova O.A., Shamray M.A., Zinchuk S.F., Krasnov K.A. Viral hepatitis B and C: similarity and diff erence. Lechashchij vrach. 2019;9:74–79. (in Russian)
9. Lopatina E.Yu., Zabozlaev F.G., Verkhotin A.A., Yudin tseva E.V., Bondarenko N.L. Extrahepatic lesions in chronic viral liver diseases. Clinical practice. 2010;2:47–51. (in Russian)
10. Monaco S., Mariotto S., Ferrari S. et al. Hepatitis C virus-associated neurocognitive and neuropsychiatric disorders: Advances in 2015. World Journal of Gastroenterology. 2015;21(42):11974–11983.
11. Barkhordarian A., Thames A.D., Du A.M. et al. Viral immune surveillance: Toward a TH17/TH9 gate to the central nervous system. Bioinformation. 2015;11(1):47–54.
12. Carvalho-Filho R.J., Narciso-Schiavon J.L., Tolentino L.H.L. et al. Central nervous system vasculitis and polyneuropathy as fi rst manifestations of hepatitis C. World Journal of Gastroenterology. 2012;18(2):188–191.
13. Adinolfi L.E., Nevola R., Lus G. et al. Chronic hepatitis C virus infection and neurological and psychiatric disorders: An overview. World J. Gastroenterol. 2015;1(8):2269–2280.
Review
For citations:
Geraskin A.E., Mosina L.M., Chegodaeva L.V. Cryoglobulinemic vasculitis as an extrahepatic manifestation of HCV infec- tion. Clinical Medicine (Russian Journal). 2020;98(9-10):709-712. (In Russ.) https://doi.org/10.30629/0023-2149-2020-98-9-10-709-712